Skip to main content
Download PDF

Response to Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management

Echo Research & Practice volume 7, pages L5–L7 (2020)Cite this article

References

  1. Harkness A, Ring L, Augustine DX, Oxborough D, Robinson S, Sharma V & Education Committee of the British Society of Echocardiography. Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British Society of Echocardiography. Echo Research and Practice 2020 7 G1–G18. (https://doi.org/10.1530/ERP-19-0050)

    Article  Google Scholar 

  2. Kanagala P & Squire IB Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management. Echo Research and Practice 2020 7 L1–L4. (https://doi.org/10.1530/ERP-20-0029)

    Article  Google Scholar 

  3. Hudson S & Pettit S. What is ‘normal’ left ventricular ejection fraction? Heart 2020 106 1445–1446. (https://doi.org/10.1136/heartjnl-2020-317604)

    Article  Google Scholar 

  4. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography 2015 28 1.e14–39.e14. (https://doi.org/10.1016/j.echo.2014.10.003)

    Article  Google Scholar 

  5. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography 2005 18 1440–1463. (https://doi.org/10.1016/j.echo.2005.10.005)

    Article  Google Scholar 

  6. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2013 62 e147–e239.

    Article  Google Scholar 

  7. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure 2012 14 803–869. (https://doi.org/10.1093/eurjhf/hfs105)

    Article  CAS  Google Scholar 

  8. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure 2016 18 891–975. (https://doi.org/10.1002/ejhf.592)

    Article  Google Scholar 

  9. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine 2003 348 1309–1321. (https://doi.org/10.1056/NEJMoa030207)

    Article  CAS  Google Scholar 

  10. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J & Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine 1999 341 709–717. (https://doi.org/10.1056/NEJM199909023411001)

    Article  CAS  Google Scholar 

  11. Desai AS, Lewis EF, Li R, Solomon SD, Assmann SF, Boineau R, Clausell N, Diaz R, Fleg JL, Gordeev I, et al. Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. American Heart Journal 2011 162 966.e10–972.e10. (https://doi.org/10.1016/j.ahj.2011.09.007)

    Article  Google Scholar 

  12. Solomon SD, Claggett B, Lewis EF, Desai A, Anand I, Sweitzer NK, O'Meara E, Shah SJ, McKinlay S, Fleg JL, et al. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. European Heart Journal 2016 37 455–462. (

    Article  CAS  Google Scholar 

  13. National Institute for Health and Clinical Excellence. Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction. London, UK: NICE, 2012. (available at: (https://www.nice.org.uk/guidance/ta388)

    Google Scholar 

  14. National Institute for Health and Clinical Excellence. Chronic heart failure in adults: diagnosis and management. London, UK: NICE, 2018. (available at: (https://www.nice.org.uk/guidance/ng106)

    Google Scholar 

  15. McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. New England Journal of Medicine 2014 371 993–1004. (https://doi.org/10.1056/NEJMoa1409077)

    Article  Google Scholar 

  16. National Institute for Health and Clinical Excellence. Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure. London, UK: NICE, 2014. (available at: (https://www.nice.org.uk/guidance/ta314)

    Google Scholar 

  17. Curtis AB, Worley SJ, Adamson PB, Chung ES, Niazi I, Sherfesee L, Shinn T, St. John Sutton MS & Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. New England Journal of Medicine 2013 368 1585–1593. (https://doi.org/10.1056/NEJMoa1210356)

    Article  CAS  Google Scholar 

Download references

Funding

This article did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

  1. East Suffolk and North Essex NHS Foundation Trust, Colchester, UK

    Allan Harkness MSc

  2. West Suffolk NHS Foundation Trust, Bury St Edmunds, UK

    Liam Ring MBBS

  3. Royal United Hospitals Bath NHS Foundation Trust, Bath, UK

    Daniel X. Augustine MD

  4. Liverpool John Moores University, Research Institute for Sports and Exercise Science, Liverpool, UK

    David Oxborough PhD

  5. North West Anglia NHS Foundation Trust, Peterborough, UK

    Shaun Robinson MSc

  6. Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK

    Vishal Sharma MD

Authors
  1. Allan Harkness MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liam Ring MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel X. Augustine MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Oxborough PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shaun Robinson MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vishal Sharma MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Education Committee of the British Society of Echocardiography

Corresponding author

Correspondence to Allan Harkness MSc.

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.(http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harkness, A., Ring, L., Augustine, D.X. et al. Response to Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management. Echo Res Pract 7, L5–L7 (2020). https://doi.org/10.1530/ERP-20-0031

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1530/ERP-20-0031

Echo Research & Practice

ISSN: 2055-0464

Contact us